Results 121 to 130 of about 240,836 (199)

Management of pericardial effusion with andexanet alfa during epicardial ventricular tachycardia ablation. [PDF]

J Cardiol Cases
Nakajima M, Takada Y, Terasawa M, Satomi K, Yazaki Y.   +4 more
europepmc   +1 more source

Targeted anticoagulant reversal, unintended consequences: lessons from andexanet alfa. [PDF]

Eur Heart J Cardiovasc Pharmacother
Levy JH, Shaw JR.
europepmc   +1 more source

Coordinating emergent procedures after andexanet alfa [PDF]

American Journal of Hematology, 2019
Sarah E. Culbreth, Katelyn W. Sylvester, Jessica Rimsans, Jean M. Connors   +3 more
openaire   +2 more sources

Emergent cardiac surgery, andexanet alfa-induced heparin resistance, and prothrombotic effects: coagulation chaos?

Journal of Thrombosis and Haemostasis
Joseph R. Shaw, J. Levy
semanticscholar   +1 more source

Andexanet alfa for oral fxa inhibitor-associated major acute intracerebral hemorrhage: insights into clinically relevant thromboembolic events from the ANNEXA-I study

Jornal Vascular Brasileiro
Mateo Porres-Aguilar, L. Meillón-García, J. C. de Campos Guerra   +2 more
semanticscholar   +1 more source

Andexanet Alfa for Factor Xa Inhibitor Reversal

New England Journal of Medicine, 2016
Joseph J, Shatzel, Molly M, Daughety, Thomas G, DeLoughery   +2 more
openaire   +7 more sources

Intraoperative Heparin Resistance and Internal Carotid Artery Occlusion After Andexanet Alfa Reversal During Endovascular Treatment of a Ruptured Cerebral Aneurysm: A Case Report. [PDF]

Cureus
Kawamura S, Matsuzaki J, Yamamoto N, Yamagata T, Nishikawa M.   +4 more
europepmc   +1 more source

Wie verläuft die Anwendung von Andexanet alfa in der klinischen Routine?

InFo Neurologie + Psychiatrie
C. Weimar
semanticscholar   +1 more source

Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database. [PDF]

Drug Saf
Roberto G, Parmeggiani L, Flaccavento A, Vannacci A, Mannaioni G, Gini R, Virgili G, Tuccori M.   +7 more
europepmc   +1 more source

165 An Analysis of the Use of Andexanet Alfa at the University of Utah Hospital

Research and Practice in Thrombosis and Haemostasis
James R. Gustat, Aubrey E. Jones, Daniel M. Witt   +2 more
semanticscholar   +1 more source